Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Egypt · Delayed Price · Currency is EGP

79.53

-1.26 (-1.56%)

At close: Mar 15, 2026

Revenue by Segment

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceuticals	7.59B	5.23B	3.96B	3.41B	2.89B
Pharmaceuticals Growth	45.09%	32.27%	16.03%	18.13%	-15.40%
Total	7.59B	5.23B	3.96B	3.41B	2.89B
Total Growth	45.09%	32.27%	16.03%	18.13%	-15.40%

Revenue by Geography

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Egypt	5.05B	3.62B	2.98B	2.65B	2.27B
Egypt Growth	39.45%	21.50%	12.62%	16.79%	-18.15%
Export	2.50B	1.59B	965.10M	752.98M	615.65M
Export Growth	57.04%	64.96%	28.17%	22.31%	-3.81%
Unallocated	35.84M	15.08M	7.39M	7.11M	2.06M
Unallocated Growth	137.64%	104.12%	3.94%	244.63%	-
Total	7.59B	5.23B	3.96B	3.41B	2.89B
Total Growth	45.09%	32.26%	16.04%	18.13%	-15.40%

Source: S&P Global Market Intelligence.